Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Levothyroxine sodium by Xeris Biopharma for Hypothyroidism: Likelihood of Approval
Levothyroxine sodium is under clinical development by Xeris Biopharma and currently in Phase II for Hypothyroidism. According to GlobalData, Phase...